Decoy Therapeutics is trading 7.2% higher at $2.48 after hours, with no fresh company-specific announcement identified to explain the rebound.
- The stock closed at $2.31 on September 28, 2026; recent company headlines predate this session.
- Reuters reported U.S. stocks fell during the regular session as higher oil prices and Treasury yields weighed on sentiment amid uncertainty over U.S.-Iran talks. This may provide context but does not establish the cause of the after-hours rise.